It totally could. If they announce materials are ready for ITV-1 clinical trials and/or that's finally underway, it should get a nice pop!
Installation of Equipment at VetProm Facility Enzolytics, Inc. purchased and installed equipment necessary for production of the ITV-1 immunotherapy for the clinical trials being design by Clinic Design. The original equipment had to be returned because of damage to the centrifuge which, along with other issues encountered by IMPL, delayed the scheduled production expected in October. The new expected production date has been rescheduled for January of 2022. (Page 22)
In the meantime this trades bearishly amid brief little spikes that get everyone's hopes up. MM's and algos definitely seem wonky and I'm not convinced there isn't a long line of debt conversion deals or other parties unloading shares. Whoknows, but .15 isn't unreasonable.